Drawing based on the label description. No photo yet.
“27 mg, Gray, capsule shaped, imprinted with "M" in a box and "27" on one side in black ink”
M 27 pill
Pill with imprint M 27 is gray, capsule, 8 mm and has been identified as Methylphenidate Hydrochloride 27 mg. It is used for depression, ADHD and narcolepsy. It is supplied by Specgx LLC.
Controlled substance: Schedule II
Methylphenidate Hydrochloride 27 mg
- Imprint
- M 27
- Strength
- 27 mg
- Used for
- Depression, ADHD and narcolepsy
- Color
- Gray
- Shape
- Capsule / oblong
- Size
- 8 mm
- Score
- No score line
- Form
- Tablet, extended release
- Manufacturer
- Specgx LLC
- Drug class
- Stimulant (ADHD medicine)
- NDC
- 0406-0127, 0406-0127-01
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Methylphenidate used for?
Methylphenidate is used for depression, ADHD and narcolepsy.
- Medicine type
- Stimulant (ADHD medicine)
Official uses from the US prescribing label
Methylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
Limitations of Use
The use of methylphenidate hydrochloride extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.
From the FDA-approved label on DailyMed (published Sep 21, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows M 27 and the other side has no imprint.
- It is gray, capsule, 8 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
According to its label, this product is no longer being made or sold.
Ingredients
Active: Methylphenidate Hydrochloride
Inactive: Microcrystalline Cellulose, Ethylcellulose, Unspecified, Hydroxypropyl Cellulose (1600000 Wamw), Hypromellose 2910 (6 Mpa.s), Ferric Oxide Red, Ferric Oxide Yellow, Ferrosoferric Oxide, Magnesium Stearate, Medium-Chain Triglycerides, Oleic Acid, Polyethylene Glycol, Unspecified, Polyvinyl Alcohol, Unspecified, Propylene Glycol, Shellac, Silicon Dioxide, Talc, Titanium Dioxide, Triacetin
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
- UPSHER SMITH 50mg Topiramate 50 mg Gray & yellow, capsule, 8 mm Used for bipolar disorder and focal seizures
- UPSHER SMITH 25mg Topiramate 25 mg Gray & pink, capsule, 7 mm Used for bipolar disorder and focal seizures
- A ZA Paricalcitol 1 mcg Gray, capsule, 8 mm Used for overactive parathyroid glands
- 531 Minocycline Hydrochloride 45 mg Gray, capsule, 9 mm Used for chest and airway infections and acne
- U 353 Doxazosin Mesylate 4 mg Gray, capsule, 9 mm Used for high blood pressure and an enlarged prostate (BPH)
- 7 Levothyroxine Sodium 0.125 mg Gray, capsule, 9 mm Used for goiter and myxedema
Other Methylphenidate pills
-
CP 401 10mg
Methylphenidate Hydrochloride 10 mg
Green & white, capsule, 14 mm
Used for depression and ADHD
Schedule II
-
10 M
Methylphenidate Hydrochloride 10 mg
White, round, 7 mm
Used for depression and ADHD
Schedule II
-
IRONSHORE 100mg
Methylphenidate Hydrochloride 100 mg
Blue & white, capsule, 23 mm
Used for depression and ADHD
Schedule II
-
212
Methylphenidate Hydrochloride 18 mg
Yellow, round, 12 mm
Used for depression and ADHD
Schedule II
-
Tow CHEW 2point5
Methylphenidate Hydrochloride 2.5 mg
White, round, 7 mm
Used for depression and ADHD
Schedule II
-
CP 402 20mg
Methylphenidate Hydrochloride 20 mg
Blue & white, capsule, 16 mm
Used for depression and ADHD
Schedule II
-
IRONSHORE 20mg
Methylphenidate Hydrochloride 20 mg
Green & yellow, capsule, 14 mm
Used for depression and ADHD
Schedule II
-
213
Methylphenidate Hydrochloride 27 mg
Pink, round, 12 mm
Used for depression and ADHD
Schedule II